stars 1 stars 2 stars 3

CelerisAI is an AI/ML-guided drug discovery company. We combine advanced AI/ML with deep biology expertise to design novel therapeutics for high-unmet-need diseases across Inflammation & Pulmonary diseases, Cardiovascular (anti-thrombotic + vasodilators), and Oncology — faster, cheaper, and with dramatically higher probability of clinical success. Unlike most AI drug discovery companies that begin with the algorithm and search for the biology, we begin with the biology and deploy best-in-class AI/ML algorithms. Every pipeline program traces back to our founder's own academic and industry research. Our AI/ML stack: generative design, ADMET/PK/PD prediction (cuts costs >70%), target mining, and clinical outcome prediction. Let's partner to reimagine drug discovery. Reach out or visit our website. 🌐 celerisai.co.in | 📧 craval@celerisai.co.in #CelerisAI #DrugDiscovery #AIDrugDiscovery #PrecisionMedicine #TranslationalResearch #Biotech #Startup#Inflammation #Cardiovasculardiseases #Oncology #BiotechStartup #ArtificialIntellegence #AI #BDPartnerships #OpenToConnect

Website http://www.celerisai.co.in
Employees 1 (1 on RocketReach)
Founded 2026
Industry Biotechnology Research

CelerisAI Questions

Chintan Raval is the Founder and CEO of CelerisAI.

1 people are employed at CelerisAI.

Top CelerisAI Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users